Page last updated: 2024-12-08
2-trimethylsilyloxyfuran
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-trimethylsilyloxyfuran: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 188414 |
SCHEMBL ID | 2827455 |
MeSH ID | M0424410 |
Synonyms (25)
Synonym |
---|
AKOS015839963 |
inchi=1/c7h12o2si/c1-10(2,3)9-7-5-4-6-8-7/h4-6h,1-3h |
2-(trimethylsiloxy)furan, 97% |
2-trimethylsilyloxyfuran |
61550-02-5 |
(2-furanyloxy)trimethylsilane |
T1536 |
2-(trimethylsilyloxy)furan |
furan-2-yloxy(trimethyl)silane |
A18985 |
(furan-2-yloxy)trimethylsilane |
furan, 2-((trimethylsilyl)oxy)- |
2-(trimethylsiloxy)furan |
ILBCDLOQMRDXLN-UHFFFAOYSA-N |
(furan-2-yloxy)-trimethyl-silane |
SCHEMBL2827455 |
2-(trimethylsiloxy)furan, purum, >=97.0% (gc) |
mfcd00011729 |
furan,2-[(trimethylsilyl)oxy]- |
FT-0767009 |
DTXSID10977118 |
[(furan-2-yl)oxy](trimethyl)silane |
2-trimethyl silyloxyfuran |
T72713 |
BS-44018 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |